BNP Paribas Trims Stake in Boston Scientific Corporation

Institutional investor reduces holdings in medical equipment provider

Mar. 15, 2026 at 9:08am

Got story updates? Submit your updates here. ›

BNP Paribas, a major institutional investor, has trimmed its stake in Boston Scientific Corporation (NYSE:BSX) by 16.2% during the third quarter, according to a recent 13F filing with the SEC. The firm now owns 94,114 shares of the medical equipment provider's stock, valued at $9,433,000.

Why it matters

This move by a prominent institutional investor like BNP Paribas could signal broader market sentiment around Boston Scientific, a major player in the medical device industry. Institutional ownership and trading activity can influence stock price movements and investor confidence.

The details

According to the 13F filing, BNP Paribas sold 18,141 shares of Boston Scientific during the third quarter, reducing its total holdings to 94,114 shares. The firm's stake in the company was worth $9,433,000 at the end of the reporting period.

  • BNP Paribas trimmed its stake in Boston Scientific during the third quarter of the year.

The players

BNP Paribas

A major French multinational bank and financial services company.

Boston Scientific Corporation

A global medical device company that develops, manufactures, and markets a broad portfolio of products used in less-invasive medical procedures.

Got photos? Submit your photos here. ›

The takeaway

The reduction in BNP Paribas' stake in Boston Scientific could indicate broader market uncertainty or caution around the medical device company, though the reasons behind the move are not entirely clear. Investors will likely continue to monitor institutional trading activity and analyst sentiment around Boston Scientific as the company navigates the evolving healthcare landscape.